KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Share-based Compensation (2016 - 2026)

West Pharmaceutical Services has reported Share-based Compensation over the past 15 years, most recently at $6.6 million for Q1 2026.

  • Quarterly Share-based Compensation rose 407.69% to $6.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $29.1 million through Mar 2026, up 94.0% year-over-year, with the annual reading at $23.8 million for FY2025, 27.27% up from the prior year.
  • Share-based Compensation was $6.6 million for Q1 2026 at West Pharmaceutical Services, down from $6.7 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $8.5 million in Q1 2023 and troughed at $1.3 million in Q1 2025.
  • The 5-year median for Share-based Compensation is $5.9 million (2023), against an average of $5.7 million.
  • Biggest five-year swings in Share-based Compensation: tumbled 79.1% in 2023 and later skyrocketed 407.69% in 2026.
  • Tracing WST's Share-based Compensation over 5 years: stood at $6.7 million in 2022, then plummeted by 79.1% to $1.4 million in 2023, then soared by 207.14% to $4.3 million in 2024, then soared by 55.81% to $6.7 million in 2025, then decreased by 1.49% to $6.6 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods came in at $6.6 million, $6.7 million, and $8.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.